Market News

Global Anhydrous Dibasic Calcium Phosphate Market: Key Developments

On May 3, 2023, OceanTech Acquisitions, a U.S.-based a special purpose acquisition company, announced that it has entered into definitive agreement to combine Regentis Biomaterials Ltd., an Israel-based regenerative medicine company at US$ 95 million valuation. Or-Akiva, Israel-based Regentis has been working to commercialize its GelrinC orthopedic therapy to repair cartilage damage in knees and has already received a CE mark in Europe as a medical device. This orthopedic therapy requires anhydrous dibasic calcium phosphate as calcium supplement. The combined company is expected to trade on the Nasdaq once the deal is completed in the fourth quarter of 2023. Regentis shareholders are to receive US$ 95 million in OceanTech I shares at US$ 10 per share.

On April 11, 2022, Abbott, a U.S.-based global healthcare leader announced launch of Arachitol Gummies in India, a new fruit flavored product for kids and adults. Arachitol Gummies is a dietary supplement that helps maintain required levels of calcium and Vitamin D sustainably. As the body needs vitamin D to absorb calcium for better bone health, keeping recommended levels of vitamin D is essential for overall well-being. Formulated with additional essential micronutrients such as calcium and curcumin, they help support bone health and immunity. Anhydrous dibasic calcium phosphate is most common source of calcium. Launched in orange fruit flavor, these easy-to-consume gummies are approved as health supplements by the Food Safety and Standards Authority in India.

On January 18, 2022, Gadot Biochemical Industries Ltd., an Israel based food, beverage, pharmaceutical, nutritional supplement, and detergent industries announced launch of a new bone support ingredient called Cal2Mag, a combination sources of calcium and magnesium. The mineral blend is substantiated by clinical studies to offset risks of arterial calcification which are associated with supplementing with calcium as a standalone mineral. As anhydrous dibasic calcium phosphate is most common source of calcium, its use in this product can drive growth of market over forecast period.

On February 20, 2023, Apollo and Luna Co., a U.S. based brand offering health supplements of dogs launched its first product, a dog food topper supplement. The topper seeks to add flavor and essential nutrients to standard dog kibble. Formulated with natural ingredients and made in the U.S., the all-natural topper serves as a calcium supplement and flavor enhancer. The supplement is available in a peanut butter flavor and does not contain any artificial colors and flavors or grains.

Global Anhydrous Dibasic Calcium Phosphate Market: Key Trends

Awareness programs arranged for dietary supplements

Awareness programs arranged for dietary supplements can drive growth of market. For instance, on February 16, 2023, Torrent Pharmaceuticals Ltd., an India based multinational pharmaceutical company announced its first-ever 12-week-long campaign across TV and digital. The campaign is named as BeShelcalStrong, to announce entry of its brand Shelcal 500 an over-the-counter (OTC) calcium supplement brand. The TVC created under the campaign aims to address the aforementioned lack of dietary calcium amongst people by educating them to pay heed to their exhaustion and listen to their aching bones, especially after they turn 40. By depicting everyday instances, the film further highlights the need to supplement one’s diet with Shelcal 500 daily.

Launch of newer products containing anhydrous dibasic calcium phosphate

Launch of newer products containing anhydrous dibasic calcium phosphate can drive global anhydrous dibasic calcium phosphate market growth. For instance, on December 5, 2022, Shijiazhuang Junlebao Dairy Co., Ltd., a China based food production company announced launch of Le Gai, a new milk powder targeted at supporting calcium absorption in middle and old aged consumers and hopes to rejuvenate the well-established category by improving bioaccessibility and bioavailability.